» Articles » PMID: 39550416

Sex-specific GABAergic Microcircuits That Switch Vulnerability into Resilience to Stress and Reverse the Effects of Chronic Stress Exposure

Overview
Journal Mol Psychiatry
Date 2024 Nov 16
PMID 39550416
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical and preclinical studies have identified somatostatin (SST)-positive interneurons as critical elements that regulate the vulnerability to stress-related psychiatric disorders. Conversely, disinhibition of SST neurons in mice results in resilience to the behavioral effects of chronic stress. Here, we established a low-dose chronic chemogenetic protocol to map these changes in positively and negatively motivated behaviors to specific brain regions. AAV-hM3Dq-mediated chronic activation of SST neurons in the prelimbic cortex (PLC) had antidepressant drug-like effects on anxiety- and anhedonia-like motivated behaviors in male but not female mice. Analogous manipulation of the ventral hippocampus (vHPC) had such effects in female but not male mice. Moreover, the activation of SST neurons in the PLC of male mice and the vHPC of female mice resulted in stress resilience. Activation of SST neurons in the PLC reversed prior chronic stress-induced defects in motivated behavior in males but was ineffective in females. Conversely, activation of SST neurons in the vHPC reversed chronic stress-induced behavioral alterations in females but not males. Quantitation of c-Fos and FosB neurons in chronic stress-exposed mice revealed that chronic activation of SST neurons leads to a paradoxical increase in pyramidal cell activity. Collectively, these data demonstrate that GABAergic microcircuits driven by dendrite targeting interneurons enable sex- and brain-region-specific neural plasticity that promotes stress resilience and reverses stress-induced anxiety- and anhedonia-like motivated behavior. The data provide a rationale for the lack of antidepressant efficacy of benzodiazepines and superior efficacy of dendrite-targeting, low-potency GABA receptor agonists, independent of sex and despite striking sex differences in the relevant brain substrates.

Citing Articles

Transcriptome signatures of the medial prefrontal cortex underlying GABAergic control of resilience to chronic stress exposure.

Shao M, Botvinov J, Banerjee D, Girirajan S, Luscher B bioRxiv. 2024; .

PMID: 39026878 PMC: 11257543. DOI: 10.1101/2024.07.10.602959.

References
1.
Duman R, Malberg J, Thome J . Neural plasticity to stress and antidepressant treatment. Biol Psychiatry. 1999; 46(9):1181-91. DOI: 10.1016/s0006-3223(99)00177-8. View

2.
Fogaca M, Duman R . Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions. Front Cell Neurosci. 2019; 13:87. PMC: 6422907. DOI: 10.3389/fncel.2019.00087. View

3.
Luscher B, Shen Q, Sahir N . The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry. 2010; 16(4):383-406. PMC: 3412149. DOI: 10.1038/mp.2010.120. View

4.
Luscher B, Fuchs T . GABAergic control of depression-related brain states. Adv Pharmacol. 2015; 73:97-144. PMC: 4784429. DOI: 10.1016/bs.apha.2014.11.003. View

5.
Earnheart J, Schweizer C, Crestani F, Iwasato T, Itohara S, Mohler H . GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. J Neurosci. 2007; 27(14):3845-54. PMC: 2441879. DOI: 10.1523/JNEUROSCI.3609-06.2007. View